Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
Portfolio Pulse from Avi Kapoor
The article discusses three high-yielding dividend stocks in the health care sector, recommended by Wall Street's most accurate analysts. Organon & Co. (OGN) has a dividend yield of 6.65% and recent news of a new prescription product. Pfizer Inc. (PFE) offers a 5.92% yield and has a new EC-approved cancer treatment. Viatris Inc. (VTRS) yields 3.97% and recently appointed a new CFO. Analyst ratings and price targets for these stocks have been updated, with some ratings downgraded and price targets adjusted.
January 12, 2024 | 1:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pfizer Inc. has a dividend yield of 5.92% and recently received EC approval for TALZENNA in combination with XTANDI. Analysts have mixed views with some downgrades and price target cuts.
While the dividend yield is attractive and the EC approval is positive, analyst downgrades and price target cuts could create mixed sentiment among investors.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 80
NEUTRAL IMPACT
Viatris Inc. offers a 3.97% dividend yield and has appointed a new CFO. Analysts have mixed opinions, with one upgrading the price target and another downgrading the stock.
The appointment of a new CFO could be seen as a positive change, but mixed analyst ratings may lead to neutral investor sentiment in the short term.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Organon & Co. has a high dividend yield of 6.65% and recent news of a new prescription product, XACIATO 2%. Analysts have adjusted price targets with a general positive outlook.
The high dividend yield and launch of a new product could attract investors seeking income and growth, potentially boosting the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80